Zhao, Shen
Zhuang, Wu
Han, Baohui
Song, Zhengbo
Guo, Wei https://orcid.org/0000-0002-1923-6975
Luo, Feng
Wu, Lin
Hu, Yi
Wang, Huijuan
Dong, Xiaorong
Jiang, Da
Wang, Mingxia
Miao, Liyun
Wang, Qian
Zhang, Junping
Fu, Zhenming
Huang, Yihua
Xu, Chunwei
Hu, Longyu
Li, Lei
Hu, Rong
Yang, Yang
Li, Mengke
Yang, Xiugao
Zhang, Li
Huang, Yan
Fang, Wenfeng
Funding for this research was provided by:
National Natural Science Foundation of China (82002408, 82241232)
Article History
Received: 2 November 2022
Accepted: 31 May 2023
First Online: 12 June 2023
Competing interests
: L.H. is an employee of HaploX Biotechnology Co., Ltd. L.L., R.H., Y.Y., M.L., and X.Y. are employees of CSPC Pharmaceutical Group Co., Ltd. L.Z. has received research support from AstraZeneca, Eli Lilly, and Roche. The remaining authors have declared no competing interests.